Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Median PS Value

: $34.27 (As of Today)

View and export this data going back to 2009. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Takeda Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $18.664. Takeda Pharmaceutical Co's 10-Year median PS Ratio is 1.8362. Therefore, the Median PS Value for today is $34.27.

As of today (2024-04-18), Takeda Pharmaceutical Co's share price is $26.52. Takeda Pharmaceutical Co's Median PS Value is $34.27. Therefore, Takeda Pharmaceutical Co's Price to Median PS Value for today is 0.77.

The historical rank and industry rank for Takeda Pharmaceutical Co's Median PS Value or its related term are showing as below:

TKPHF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.68 Med: 0.82 Max: 0.98
Current: 0.77

During the past 13 years, the highest Price to Median PS Value of Takeda Pharmaceutical Co was 0.98. The lowest was 0.68. And the median was 0.82.

TKPHF's Price-to-Median-PS-Value is ranked worse than
50.1% of 501 companies
in the Drug Manufacturers industry
Industry Median: 0.77 vs TKPHF: 0.77

Takeda Pharmaceutical Co Median PS Value Historical Data

The historical data trend for Takeda Pharmaceutical Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Median PS Value

44.67

41.32

39.11

39.98

39.85

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Median PS Value																39.58	39.85	36.40	35.27	37.15

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Takeda Pharmaceutical Co Price-to-Median-PS-Value Distribution

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Price-to-Median-PS-Value falls into.

Takeda Pharmaceutical Co Median PS Value Calculation

Takeda Pharmaceutical Co's Median PS Value for today is calculated as

Median PS Value	=	Revenue per Share (TTM)	*	10-Year Median PS Ratio
	=	18.664	*	1.8362
	=	34.27

10-Year Median PS Ratio is 1.8362.
Takeda Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $18.664.

Takeda Pharmaceutical Co (OTCPK:TKPHF) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Takeda Pharmaceutical Co's Price to Median PS Value for today is calculated as

Price to Median PS Value	=	Share Price	/	Median PS Value
	=	26.52	/	34.27
	=	0.77

Takeda Pharmaceutical Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (Takeda Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Median PS Value

Comparable Companies

Traded in Other Exchanges

TAK:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.